Abstract
Cold atmospheric plasma-activated hydrogel (PAH) have proven effective as a novel anticancer method. In this study, air discharge plasma-activated pluronic F127 hydrogel (PAHPF127) combined with nitrogenous nanographene oxide (GO/N) are proposed for enhancing anticancer efficacy. The results showed that PAHPF127 could effectively load various reactive oxygen and nitrogen species generated by plasma without adversely affecting the physicochemical properties. In addition, the in vitro results indicated that the PAHPF127 had an anticancer effect on B16F10 melanoma cells, and the combination treatment reduced cancer cell viability to 49%, compared to 73% for PAHPF127 and 88% for GO/N alone, and increased intracellular ROS levels by 2.4-fold. These findings highlight the potential of PAHPF127-GO/N as an innovative platform for enhanced plasma-induced cancer therapy.
| Original language | English |
|---|---|
| Article number | 70080 |
| Journal | Plasma Processes and Polymers |
| Volume | 22 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- anticancer effect
- cold atmospheric plasma
- nitrogenous nanographene oxide
- plasma-activated hydrogels
- reactive oxygen and nitrogen species
Fingerprint
Dive into the research topics of 'Air Discharge Plasma-Activated Hydrogels Combined With Nitrogenous Nanographene Oxide Exhibit Enhanced Anticancer Efficacy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver